000			02214 a2200589 4500
005			20250513031640.0
264		0	_c19950531
008			199505s 0 0 eng d
022			_a0006-4971
040			_aNLM _beng _cNLM
100	1		_aGunther, R
245	0	0	_aBiotherapy for xenografted human central nervous system leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin. _h[electronic resource]
260			_bBlood _cMay 1995
300			_a2537-45 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntigens, CD _ximmunology
650	0	4	_aAntigens, CD19
650	0	4	_aAntigens, Differentiation, B-Lymphocyte _ximmunology
650	0	4	_aBlood-Brain Barrier
650	0	4	_aBone Marrow _xpathology
650	0	4	_aCell Movement
650	0	4	_aCentral Nervous System _xpathology
650	0	4	_aDNA, Neoplasm _xanalysis
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aImmunotoxins _xadministration & dosage
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aInjections, Intravenous
650	0	4	_aInjections, Spinal
650	0	4	_aLeukemic Infiltration _xdrug therapy
650	0	4	_aMeninges _xpathology
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aN-Glycosyl Hydrolases
650	0	4	_aNeoplasm Transplantation
650	0	4	_aNeoplastic Cells, Circulating
650	0	4	_aPlant Proteins _xadministration & dosage
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aRibosome Inactivating Proteins, Type 1
650	0	4	_aSpecific Pathogen-Free Organisms
650	0	4	_aTransplantation, Heterologous
700	1		_aChelstrom, L M
700	1		_aTuel-Ahlgren, L
700	1		_aSimon, J
700	1		_aMyers, D E
700	1		_aUckun, F M
773	0		_tBlood _gvol. 85 _gno. 9 _gp. 2537-45
999			_c7536580 _d7536580